?php print render($page['highlighted']); ?>
NOTICE TO PROCEED
Year | Title / Procurement Project | Reference Number | PO/Contract No. | Awardee/Supplier | Effectivity and Expiration Date of Contract |
NTP Contract Date![]() |
Date Posted |
---|---|---|---|---|---|---|---|
2023 | Print and Publication of Healthy Pilipinas Priority Programs in Leading National Newspaper (Broadsheet and Tabloid) | IB No. 2023-001 | GOP-C-2023-002 | Adrow Creatives Incorporated | February 14, 2023 to February 22, 2023 | December 31, 2023 | February 28, 2023 |
2021 | Construction of New Tabaco Quarantine Building (2-Storey) | WB-PCERP-35-2021 | WB-C-2021-07-018 | JODANS ENGINEERING | September 30, 2021 to September 26, 2022 | September 20, 2023 | October 1, 2021 |
2023 | PROCUREMENT OF CAPECITABINE | IB NO. 2023-044 | GOP-C-2023-038 | March 29, 2023 to May 29, 2023 | March 27, 2023 | March 30, 2023 | |
2023 | PROCUREMENT OF NUCLEIC ACID AMPLIFICATION TESTING REAGENTS WITH MACHINE TIE-UP | IB NO. 2023-115 | GOP-C-2023-042 | March 27, 2023 to May 12, 2023 | March 24, 2023 | March 29, 2023 | |
2023 | Procurement of Service Provider for the Rental of Photocopier Machines for the Department of Health - Central Office | IB No. 2023-103 | GOP-C-2023-021 | U-Bix Corporation | March 31, 2023 to December 31, 2023 | March 24, 2023 | March 31, 2023 |
2023 | PROCUREMENT OF DOXORUBICIN | IB NO. 2023-049 | GOP-C-2023-040 | March 27, 2023 to May 29, 2023 | March 23, 2023 | March 27, 2023 | |
2023 | Procurement of Rituximab | IB No. 2023-085 | GOP-C-2023-037 | Zuellig Pharma Corporation - Interphil Laboratories, Inc., Joint Venture | March 23, 2023 to May 22, 2023 | March 22, 2023 | March 26, 2023 |
2023- | PROCUREMENT OF GEMCITABINE ITEM NO. 2 | IB NO. 2023-043 | GOP-C-2023-035 | L. Meyerf Pharma, Inc. | March 23, 2023 to May 23, 2023 | March 21, 2023 | March 23, 2023 |
2023 | PROCUREMENT OF OXALIPLATIN | IB NO. 2023-042 | GOP-C-2023-033 | March 24, 2023 to May 24, 2023 | March 21, 2023 | March 27, 2023 | |
2023 | PROCUREMENT OF BICALUTAMIDE | IB NO. 2023-045 | GOP-C-2023-039 | L. Meyerf Pharma, Inc. | March 23, 2023 to May 23, 2023 | March 21, 2023 | March 23, 2023 |